Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.21.2
Summary of Significant Accounting Policies (Details)
$ in Millions
1 Months Ended
Jan. 31, 2021
USD ($)
fostamatinib  
Government contract $ 16.5